Investor
Medipal Holdings
CVC Domestic (Japan)
Operating company investing from its balance sheet
2026 activity
- 1 tracked 2026 round(s)
- Participated in rounds totalling ¥3.5B. This is the sum of whole rounds, including other investors' money and any debt; it is not this investor's own investment.
Classification source: https://prtimes.jp/main/html/rd/p/000000047.000075935.html
Grey amounts aren't counted in totals. † includes debt or other non-equity.
| Date | Company | Stage | Amount | Investors | Sector |
|---|---|---|---|---|---|
| 26 Feb 2026 | MTMetagen Therapeutics | Series B | ¥3.5B | Canon Marketing Japan MIRAI FundMatsukiyoCocokara & CompanyMedipal Holdings | BiotechDeep tech |